| Diff4VS: HIV-inhibiting Molecules Generation with Classifier Guidance Diffusion for Virtual Screening | Jul 20, 2024 | Drug Design | CodeCode Available | 0 |
| Decomposed Direct Preference Optimization for Structure-Based Drug Design | Jul 19, 2024 | Drug Design | —Unverified | 0 |
| Antibody DomainBed: Out-of-Distribution Generalization in Therapeutic Protein Design | Jul 15, 2024 | Domain GeneralizationDrug Design | —Unverified | 0 |
| Token-Mol 1.0: Tokenized drug design with large language model | Jul 10, 2024 | Drug DesignDrug Discovery | —Unverified | 0 |
| Leveraging Latent Evolutionary Optimization for Targeted Molecule Generation | Jul 2, 2024 | Drug DesignDrug Discovery | —Unverified | 0 |
| DCI: An Accurate Quality Assessment Criteria for Protein Complex Structure Models | Jun 30, 2024 | Drug Design | —Unverified | 0 |
| YZS-model: A Predictive Model for Organic Drug Solubility Based on Graph Convolutional Networks and Transformer-Attention | Jun 27, 2024 | Drug DesignDrug Discovery | CodeCode Available | 0 |
| Molecular Diffusion Models with Virtual Receptors | Jun 26, 2024 | Drug DesignProtein Folding | —Unverified | 0 |
| A Comprehensive Review of Emerging Approaches in Machine Learning for De Novo PROTAC Design | Jun 24, 2024 | Drug DesignDrug Discovery | —Unverified | 0 |
| Explainable Machine Learning and Deep Learning Models for Predicting TAS2R-Bitter Molecule Interactions | Jun 21, 2024 | Drug DesignExplainable Models | —Unverified | 0 |
| Geometric-informed GFlowNets for Structure-Based Drug Design | Jun 16, 2024 | Drug DesignDrug Discovery | —Unverified | 0 |
| From Theory to Therapy: Reframing SBDD Model Evaluation via Practical Metrics | Jun 13, 2024 | Drug DesignDrug Discovery | CodeCode Available | 0 |
| SemlaFlow -- Efficient 3D Molecular Generation with Latent Attention and Equivariant Flow Matching | Jun 11, 2024 | 3D GenerationDrug Design | —Unverified | 0 |
| Diffusion Models in De Novo Drug Design | Jun 7, 2024 | Computational chemistryDenoising | —Unverified | 0 |
| Predicting solvation free energies with an implicit solvent machine learning potential | May 31, 2024 | Drug DesignGraph Neural Network | CodeCode Available | 0 |
| Retro-prob: Retrosynthetic Planning Based on a Probabilistic Model | May 25, 2024 | Drug DesignRetrosynthesis | —Unverified | 0 |
| PILOT: Equivariant diffusion for pocket conditioned de novo ligand generation with multi-objective guidance via importance sampling | May 23, 2024 | Drug DesignDrug Discovery | —Unverified | 0 |
| Guided Multi-objective Generative AI to Enhance Structure-based Drug Design | May 20, 2024 | Drug DesignDrug Discovery | CodeCode Available | 0 |
| Improving Targeted Molecule Generation through Language Model Fine-Tuning Via Reinforcement Learning | May 10, 2024 | Drug DesignLanguage Modeling | —Unverified | 0 |
| DrugLLM: Open Large Language Model for Few-shot Molecule Generation | May 7, 2024 | Drug DesignDrug Discovery | —Unverified | 0 |
| Optimized Drug Design using Multi-Objective Evolutionary Algorithms with SELFIES | May 1, 2024 | Drug DesignEvolutionary Algorithms | —Unverified | 0 |
| Deep Lead Optimization: Leveraging Generative AI for Structural Modification | Apr 30, 2024 | Drug Design | —Unverified | 0 |
| Leveraging Active Subspaces to Capture Epistemic Model Uncertainty in Deep Generative Models for Molecular Design | Apr 30, 2024 | Bayesian InferenceDiversity | —Unverified | 0 |
| ControlMol: Adding Substructure Control To Molecule Diffusion Models | Apr 22, 2024 | 3D Molecule GenerationDrug Design | —Unverified | 0 |
| Multi-objective generative AI for designing novel brain-targeting small molecules | Apr 16, 2024 | Drug DesignGraph Neural Network | —Unverified | 0 |
| AUTODIFF: Autoregressive Diffusion Modeling for Structure-based Drug Design | Apr 2, 2024 | Drug DesignDrug Discovery | —Unverified | 0 |
| AlphaFold2 for protein structure prediction: Best practices and critical analyses | Mar 19, 2024 | Drug DesignProtein Structure Prediction | —Unverified | 0 |
| DecompOpt: Controllable and Decomposed Diffusion Models for Structure-based Molecular Optimization | Mar 7, 2024 | Drug DesignDrug Discovery | —Unverified | 0 |
| Stabilizing Policy Gradients for Stochastic Differential Equations via Consistency with Perturbation Process | Mar 7, 2024 | Drug DesignPolicy Gradient Methods | —Unverified | 0 |
| DeepBioisostere: Discovering Bioisosteres with Deep Learning for a Fine Control of Multiple Molecular Properties | Mar 5, 2024 | Drug Design | —Unverified | 0 |
| Rethinking Specificity in SBDD: Leveraging Delta Score and Energy-Guided Diffusion | Mar 4, 2024 | Contrastive LearningDrug Design | —Unverified | 0 |
| Exploring Gene Regulatory Interaction Networks and predicting therapeutic molecules for Hypopharyngeal Cancer and EGFR-mutated lung adenocarcinoma | Feb 27, 2024 | Drug Design | —Unverified | 0 |
| Structure-Based Drug Design via 3D Molecular Generative Pre-training and Sampling | Feb 22, 2024 | Drug DesignMolecular Docking | —Unverified | 0 |
| Re-Dock: Towards Flexible and Realistic Molecular Docking with Diffusion Bridge | Feb 18, 2024 | Drug DesignMolecular Docking | —Unverified | 0 |
| Learning big logical rules by joining small rules | Jan 29, 2024 | Drug DesignInductive logic programming | CodeCode Available | 0 |
| Navigating the Maize: Cyclic and conditional computational graphs for molecular simulation | Jan 22, 2024 | Active LearningComputational chemistry | —Unverified | 0 |
| Quantum-Inspired Machine Learning for Molecular Docking | Jan 22, 2024 | Blind DockingCombinatorial Optimization | —Unverified | 0 |
| DeepRLI: A Multi-objective Framework for Universal Protein--Ligand Interaction Prediction | Jan 19, 2024 | Contrastive LearningDrug Design | CodeCode Available | 0 |
| Rigid Protein-Protein Docking via Equivariant Elliptic-Paraboloid Interface Prediction | Jan 17, 2024 | Drug Design | CodeCode Available | 0 |
| Empirical Evidence for the Fragment level Understanding on Drug Molecular Structure of LLMs | Jan 15, 2024 | Drug DesignDrug Discovery | CodeCode Available | 0 |
| Deep Manifold Transformation for Protein Representation Learning | Jan 12, 2024 | Drug DesignRepresentation Learning | —Unverified | 0 |
| Hybrid quantum cycle generative adversarial network for small molecule generation | Dec 28, 2023 | DiversityDrug Design | —Unverified | 0 |
| Cellular forgetting, desensitisation, stress and aging in signalling networks. When do cells refuse to learn more? | Dec 28, 2023 | Change DetectionDrug Design | —Unverified | 0 |
| PlayMolecule Viewer: a toolkit for the visualization of molecules and other data | Dec 22, 2023 | Data VisualizationDrug Design | —Unverified | 0 |
| CrossBind: Collaborative Cross-Modal Identification of Protein Nucleic-Acid-Binding Residues | Dec 19, 2023 | Contrastive LearningDrug Design | CodeCode Available | 0 |
| Automating reward function configuration for drug design | Dec 15, 2023 | Drug DesignDrug Discovery | —Unverified | 0 |
| NovoMol: Recurrent Neural Network for Orally Bioavailable Drug Design and Validation on PDGFRα Receptor | Dec 3, 2023 | Drug Design | CodeCode Available | 0 |
| From Byte to Bench to Bedside: Molecular Dynamics Simulations and Drug Discovery | Nov 28, 2023 | Drug DesignDrug Discovery | —Unverified | 0 |
| GlycoNMR: Dataset and benchmarks for NMR chemical shift prediction of carbohydrates with graph neural networks | Nov 28, 2023 | Drug Designmolecular representation | —Unverified | 0 |
| Docking-based generative approaches in the search for new drug candidates | Nov 22, 2023 | Drug DesignMolecular Docking | —Unverified | 0 |